GAITHERSBURG, Md., Jan. 7 /PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI)
announced today that it will present at the JP Morgan H&Q 20th Annual
Healthcare Conference at 8:30 a.m. Pacific Time on Thursday January 10, 2002.
The conference is being held at Westin St. Francis in San Francisco from
January 7-10, 2002. MedImmune's presentation will be webcast live for
investors and available for replay for a period of three months following the
conference at http://www.jpmhq.com/ .
MedImmune, Inc. is a biotechnology company focused on developing and
marketing products that address medical needs in areas such as infectious
disease, immune regulation and cancer. Headquartered in Gaithersburg,
Maryland, MedImmune has manufacturing facilities in Frederick, Maryland and
Nijmegen, the Netherlands.
This announcement may contain, in addition to historical information,
certain forward-looking statements that involve risks and uncertainties. Such
statements reflect management's current views and are based on certain
assumptions. Actual results could differ materially from those currently
anticipated as a result of a number of factors, including risks and
uncertainties discussed in the company's filings with the U.S. Securities and
Exchange Commission. The company is developing several products for potential
future marketing. There can be no assurance that such development efforts
will succeed, that such products will receive required regulatory clearance or
that, even if such regulatory clearance were received, such products would
ultimately achieve commercial success.
SOURCE MedImmune, Inc.
 back to top
Related links:
http://www.medimmune.com
http://www.jpmhq.com
CONTACT:
Lori Weiman, Senior Director, Corporate
Communications, +1-301-527-4321, or William Roberts, Manager,
Investor Relations, +1-301-527-4358, both of MedImmune, Inc.
|
